Tricuspid regurgitation pressure gradient in the PCSO-524 and placebo groups. by Nattapon Riengvirodkij (11268720)

Subjects:

Cinnamaldehyde is a specific ligand for HL-IR. by Ceyan Kuang (8554557)

A list of the genes that are significantly downregulated or upregulated in <i>Gpdh1</i>^{<i>A10/B18</i>}<i>; Ldh</i>^<i>16/17</i> double mutant larvae relative to... by Madhulika Rai (4352803)

(A) Hierarchical clustering results of differential proteins in the Model.vs.WKY; (B) Differential protein enrichment bar chart in the Model.vs.WKY; (C) Significantly enriched path... by Xiao Zhang (152326)

Additional loss of life expectancy and cost per life-year saved resulting from changes in colorectal cancer stage due to a 1-year diagnostic delay. by Hiroaki Saito (24514)

Estimated coefficients from the SARIMA model of new COVID-19 deaths assuming a gradual effect following the implementation of two ETSs and one executive order in Oregon. by Raul Cruz-Cano (3751321)

Voxel representation of a 3D binary image (left) and its corresponding graph of connected pore space voxels (right). by Mouad Klai (20818364)

Skills development and coping strategies as a consequence of the pandemic. <i><i>Results displayed in percentages.</i></i> by Katy Andrews (22311170)

Changes in vitamin A level from colostrum to mature milk (n = 10). by Saman Lashkari (21440154)

Graphs showing reproduction of selected South American annual case (a) and death (b) data using 1000 parameter sets drawn from post-burn-in distribution obtained from 4 Markov chai... by Keith Fraser (1868587)

Data Sheet 1_Placental trophoblast aging in advanced maternal age is related to increased oxidative damage and decreased YAP.docx by Song Guo (194234)

Data Sheet 2_Placental trophoblast aging in advanced maternal age is related to increased oxidative damage and decreased YAP.xls by Song Guo (194234)

Exposure to biologics during pregnancy does not affect placental antibody transfer of anti-SARS-CoV-2 neutralizing antibodies, but concomitant corticosteroid exposure may decrease... by Donna E. Leet (22772478)

Linear Mixed-Effects Model analysis of bone mineral density changes in relation to urinary cadmium levels in a 3-Year Period. by Aroon La-up (14095691)

FGF18 injections increase TIMP1 and decrease MMP13 and NOGGIN, suggesting healing of degeneration induction of anabolic effect. by Flavia Gomes Velasque Gama (21175112)

Everolimus decreased CD89 deposits in α1^KICD89^Tg mice. by Alexandra Cambier (22307216)

Presentation 1_Decreased brain-derived neurotrophic factor expression in chronic kidney disease: integrated clinical and experimental evidence.pptx by Juan Chen (61123)

“…</p>Conclusion<p>This study integrated meta-analysis, murine model validation, and single-cell transcriptomic profiling to demonstrate a significant reduction of BDNF in CKD. Furthermore, renal BDNF expression decreased locally, predominantly originating from proximal tubule cells, macrophages, and podocytes, possibly epigenetically inhibited by the upregulation of lnc RNA Bdnf-as.…”

Data Sheet 2_Ruxolitinib synergizes with regulatory T cells to improve inflammation but has no added benefits in decreasing albuminuria in SLE.pdf by Mi-Ae Lyu (20413646)

“…UCB-Treg and ruxolitinib combination also downregulates the soluble form of inflammatory cytokines including IFN-γ, IP-10, TNF-α, IL-6, sCD40L, IL-17A, IL-17F, IL-1α, and LIF in cocultures. The addition of ruxolitinib increases UCB-Treg cell persistence in peripheral blood in vivo and decreases the soluble form of human inflammatory cytokines including IFN-γ, TNF-α, and sCD40L in plasma along with improvement of skin lesions in SLE xenografts. …”

Data Sheet 3_Ruxolitinib synergizes with regulatory T cells to improve inflammation but has no added benefits in decreasing albuminuria in SLE.pdf by Mi-Ae Lyu (20413646)

“…UCB-Treg and ruxolitinib combination also downregulates the soluble form of inflammatory cytokines including IFN-γ, IP-10, TNF-α, IL-6, sCD40L, IL-17A, IL-17F, IL-1α, and LIF in cocultures. The addition of ruxolitinib increases UCB-Treg cell persistence in peripheral blood in vivo and decreases the soluble form of human inflammatory cytokines including IFN-γ, TNF-α, and sCD40L in plasma along with improvement of skin lesions in SLE xenografts. …”

Data Sheet 1_Ruxolitinib synergizes with regulatory T cells to improve inflammation but has no added benefits in decreasing albuminuria in SLE.pdf by Mi-Ae Lyu (20413646)

“…UCB-Treg and ruxolitinib combination also downregulates the soluble form of inflammatory cytokines including IFN-γ, IP-10, TNF-α, IL-6, sCD40L, IL-17A, IL-17F, IL-1α, and LIF in cocultures. The addition of ruxolitinib increases UCB-Treg cell persistence in peripheral blood in vivo and decreases the soluble form of human inflammatory cytokines including IFN-γ, TNF-α, and sCD40L in plasma along with improvement of skin lesions in SLE xenografts. …”